FDA Adverse Event Injury Summary report: N

IMPELLA RECOVER LP 2.5 PECUTANEOUS CARDIAC S

MDR report key: 1111016 · Received August 12, 2008

Report

Report Number
1220648-2008-00009
Event Type
Injury
Date Received
August 12, 2008
Date of Event
July 11, 2008
Report Date
July 13, 2008
Manufacturer
ABIOMED
Product Code
KFM
PMA / PMN Number
K063723
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE WAS NOT RETURNED TO THE MANUFACTURER; THEREFORE, A FAILURE ANALYSIS CANNOT BE COMPLETED TO DETERMINE THE ROOT CAUSE OF THE REPORTED DEVICE DEFECT OR THE RELATIONSHIP OF THE DEVICE TO THE REPORTED EVENT (BLOOD LOSS REQUIRING TRANSFUSION). A SUPPLEMENTAL MEDWATCH REPORT WILL BE SUBMITTED IF ADDITIONAL INFORMATION CAN BE OBTAINED.

Description of Event or Problem · 1

THE COMPLAINANT HAS REPORTED THAT A PATIENT UNDERWENT A PROCEDURE INVOLVING AN IMPELLA 2.5 DEVICE. DURING THE INITIAL INSERTION TECHNIQUE OF THE DEVICE, THE 13FR PEEL-AWAY INTRODUCER, AN ACCESSORY OF THE DEVICE'S INTRODUCER KIT, WAS OBSERVED TO BE LEAKING FROM THE HEMOSTATIC VALVE AROUND THE IMPELLA CATHETER. THE BLEEDING WAS DISCOVERED WHILE THE PHYSICIAN WAS BACKLOADING THE 7FR SHEATH. THE SHEATH CONTINUED TO LEAK AROUND THE IMPELLA CATHETER. AN ESTIMATED BLOOD LOSS OF 600CC WAS OBSERVED FROM THE HEMOSTATIC VALVE, SO A BLOOD TRANSFUSION WAS PERFORMED INTRA-OPERATIVELY. IT WAS DECIDED TO GIVE 2 UNITS OF PACKAGED RED BLOOD CELLS BEFORE REMOVAL OF PUMP. THE PATIENT WAS ALSO GIVEN 40MG IV LASIX INTRA-PROCEDURE, AND TOTAL UOP FOR THE PROCEDURE WAS 2 LITRES. THE PATIENT SEEMED MUCH IMPROVED AFTER THE PROCEDURE (SBP STAYING AROUND 115, PAP DECREASED TO 59/26). THE IMPELLA WAS SUCCESSFULLY WEANED OVER APPROXIMATELY 30 MIN, WITHOUT HEMODYNAMIC COMPROMISE, AND THE PATIENT WAS SUBSEQUENTLY DISCHARGED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 IMPELLA RECOVER LP 2.5 PECUTANEOUS CARDIAC S KFM ABIOMED

Patients

Seq Age Sex Outcome Treatment
1 UNK Required Intervention